الابحاث

South Egypt Cancer Institute

Assiut University

Department of Pediatric Oncology
# Title Research Member Research Year
61 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom 		Prof. Amany Mohamed Ali Ahmed 2018
62 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2018
63 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute 		Dr. Azaa Shibl Sayed Mahmoud 2018
64 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Prof. Heba Abdel-Razik Sayed Hussein 2018
65 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Samar Muhammad mansour 2018
66 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute 		Prof. Heba Abdel-Razik Sayed Hussein 2018
67 Bloodstream Infections in Febrile Neutropenic
Pediatric Cancer Patients: Microbiological and
Sepsis Biomarkers Insight 		Dr. Khaled Fathy Riad Osman 2018
68 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Mahmoud Motaz Elzembely 2018
69 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Shaimaa / Elsayyed Youssef / Ahmed 2018
70 P-458 Pain Experience Profile in Children with Cancer: Prospective Analysis of 2216 Treatment Days in a Developing Country Dr. Khaled Fathy Riad Osman 2017